Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07861204 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
High-grade proteinuria is one of the key determinants of adverse renal prognosis in patients with primary membranous nephropathy (PMN).The main purpose of this study is to determine whether Rituximab combined with Cyclosporine is superior to Rituximab monotherapy in inducing remission of proteinuria in patients with PMN.
Trial Details
NCT Number NCT07861204
Lead Sponsor Peking University First Hospital
Collaborators: China Rehabilitation Research Center, Fu Xing Hospital, Capital Medical University, People's Hospital of Beijing Daxing District
Conditions
(from sponsor)		 Membranous Nephropathy
Related terms Glomerulonephritis, Membranous
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov